Suven Life Sciences inks pact to buy assets of Rising Pharma
- 5 years ago
Suven Life Sciences announced multiple developments in the past couple of days. They are going to buy assets of Aceto Corporation’s Rising Pharma in the US and that investment is around USD 15 million and separately the company is setting up a subsidiary in the US under its Contract research and manufacturing services (CRAMS) segment and that would entail an additional USD 75 million in terms of investment eventually. Chairman and CEO, Venkat Jasti shared more details.